https://healthpromotionresearch.org/Faculty Parent Page: Faculty id: 27768 Active Page: detailsid:27766
Motolani E. Adedipe (née Ogunsanya), DPh, MS, PhD

Motolani E. Adedipe (née Ogunsanya), DPh, MS, PhD

Associate Professor, Department of Family and Preventive Medicine

motolani-adedipe@ouhsc.edu

Motolani E. Adedipe, DPh, Ph.D. is an Associate Professor in the Department of Family and Preventive Medicine at the University of Oklahoma Health Sciences. She has both clinical (DPh) and graduate (Ph.D.) training in pharmacy. She earned her MSc and Ph.D degrees in Pharmaceutical Sciences from The University of Texas at Austin in 2014 and 2017, respectively.

Through her research, Dr. Adedipe aims to become an independent pharmacist researcher and leader who conducts community-engaged, mixed methods, and population-based cohort studies that focus on examining and building interventions around quality of life (QoL) issues relevant to underserved communities.

Dr. Adedipe’s research focuses on health economics and outcomes research using mixed methodologies. Her research interests primarily involve understanding health behaviors among underserved, minority groups and the use of patient-reported outcomes to capture disease burden in patients with rare diseases, cancer, and other disease conditions. Additional research interests include psychometrics (instrument development and validation) and examining QoL through theoretical frameworks and large-scale retrospective database analyses. She is currently testing the efficacy of a mHealth platform for Black prostate cancer survivors to improve their QoL and exploring socioeconomic influences on cutaneous lupus erythematosus diagnosis and outcomes

Education:

Degree-Granting Education:

  • University of Lagos, Lagos, Nigeria - B.Pharm, 2003

Postgraduate Education:

  • Master of Science in Pharmaceutical Sciences, The University of Texas at Austin
  • Doctor of Philosophy in Pharmaceutical Sciences, The University of Texas at Austin
  • Doctor of Pharmacy, Oklahoma State Board of Pharmacy

Funding:

  1. Health Disparity Research Award, Department of Defense, Oklahoma City, OK
    Investigators: Adedipe ME, Odedina FT, Young ME, Nagykaldi Z, McIntosh A, Zhao D, Kendzor D
    Role: PI
    Amount: $1,300,000
    Duration: 09/30/2024 - 09/29/2027
    Title: “Development and Preliminary Evaluation of a Tailored mHealth App Designed to Improve Quality-of-Life Outcomes in Ethnically-Diverse Black Prostate Cancer Survivors”
  2. Research Award, Advancing Cancer Treatment (ACT) and Prostate Cancer Clinical Trials Consortium (PCCTC)
    Investigators: Adedipe ME, Neil J, Doescher M, Alexander A.
    Role: PI
    Amount: $100,000 per year
    Duration: 06/15/2024 - 06/15/2026
    Title: “A multipronged approach to recruiting African-American and Hispanic men from Oklahoma to the PROMISE Trial”
  3. Award, Cancer Health Equity Research Centers, American Cancer Society
    Investigators: Walker J, Kendzor D, Businelle M, Jordan N, Alexander A, Adedipe ME
    Role: Co-Investigator
    Duration: 09/30/2023 - 09/29/2025
    Title: “Interventions to Overcome Upstream Factors Causing High Cancer Mortality Rates for African Americans”
  4. Institutional Development Award (IDeA) Grant, University of Oklahoma, James/U54GM104938
    Investigators: James J, VanWagoner T, Adedipe ME
    Role: Investigator
    Duration: 09/01/2023 - 06/30/2033
    Title: “National Institute of General Medical Sciences U54 Cooperative Agreement”
  5. Grant, Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award, Department of Defense
    Investigators: Odedina FT, Ngufor C, Merriweather A, Crook J, Adedipe ME, Gordon V, Flynn S
    Role: Co-Investigator
    Duration: 09/30/2022 - 09/29/2027
    Title: “iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men”
  6. Idea Award, Department of Defense, Dallas, TX
    Investigators: Chong BF, Adedipe ME, Werth V, Neely S
    Role: Co-PI
    Duration: 09/30/2022 - 09/29/2025
    Amount: $300,000
    Title: “Validation of the Cutaneous Lupus Erythematosus Quality of Life (CLEQoL), a CLE-Specific Patient-Reported Outcome Measure”
  7. Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15), Georgia College & State University
    Investigators: Kaninjing E, Adedipe ME, Young ME, Vanvoorhis K, Asiedu G, Kokayi A, W, Odedina
    Role: Co-PI
    Duration: 08/12/2022 - 07/31/2025
    Amount: $404,410
    Title: “Development of a theory-based framework and measures of acculturation for African immigrants”
  8. Team Science Grant Award, University of Oklahoma Health Sciences, Presbyterian Health Foundation, Oklahoma City, OK
    Investigators: Neil J, Alexander A, Adedipe ME, Doescher M, Frank-Pearce S
    Role: Co-Investigator
    Amount: $98,462
    Duration: 07/01/2022 - 06/30/2027
    Title: “A pilot randomized clinical trial of a smartphone-based application for prostate cancer education and home-based PSA screening for African American men”

Select Publications:

  1. (Accepted) Ogunsanya ME, Bolajoko O#, Saintibert J#, Hooks D#, Clifton S, Odedina FT. Mapping Behavioral Research In Post-Treatment Cancer Care In Sub-Saharan Africa: A Scoping Review. Pscyho-Oncology Journal. 2025.
  2. Kendzor DE, Davie M, Meng C#, Hart J, Frank-Pearce S, Doescher MP, Alexander AC, Businelle MS, Ogunsanya ME, Sifat MS, Boozary LK#. Incentivizing Tobacco Helpline Engagement in Persistent Poverty Counties: A Randomized Trial. American Journal of Preventive Medicine. 2025, Volume 68, Issue 2 (336-347), DOI: 10.1016/j.amepre.2024.10.014.
  3. Anyanwu PA¤, Olateju OO, Tata V, Varisco TJ, Gilbert LR, Ogunsanya ME, Essien J, Johnson ML, Thornton JD. Understanding the Financial Barriers to Treatment Among Individuals with Opioid Use Disorder: A Focus Group Study. Harm Reduction Journal. 2024: 21 (220), https://doi.org/10.1186/s12954-024-01133-4
  4. Neil J, Mao B, Shao R, Ogunsanya ME, Frank-Pearce SG, Businelle MS, Cookson M, Stratton K, Doescher M, Pharr S, Moise V, Fleshman B, Fronheiser J, Estrada K, Flores I, Bradley D, Kendrick A, & Alexander AC. (2024). A Pilot Randomized Clinical Trial of a Smartphone-Based Application for Prostate Cancer Education and At-Home PSA Screening for African American Men: A Study Protocol. Contemporary Clinical Trials. 2024:147 (107737).
  5. Ogunsanya ME, Frank-Pearce S, Chen S, Sifat M#, Cohn AM, Businelle MS, Kendzor DE. The Influence of Sociodemographic, Tobacco Use, and Mental Health Characteristics on Treatment Adherence Among Adults Enrolled in a Community-Based Tobacco Cessation Program. Addictive Behaviors Reports Journal. 2024, Vol.20, p.100568, DOI: 10.1016/j.abrep.2024.100568.
  6. Gustafson KA, Rowe C, Gavaza P, Bernknopf A, Nogid A, Hoffman A, Jones E, Showman L, Miller V, Abdel Aziz MH, Brand-Eubanks D, Po DP, Berman S, Chu A, Dave V, Devraj R, Hintze TD, Munir F, Mohamed I, Ogunsanya ME, Prudencio J, Singh D, Southwood R. L. Pharmacists’ Perceptions of Artificial Intelligence: A National Survey. Journal of the American Pharmacists Association. 2024, 102306, DOI: https://doi.org/10.1016/j.japh.2024.102306.
  7. Ogunsanya ME, Kaninjing E, Morton DJ, Dwyer K, Young ME, Odedina FT. Bridging The Gap: A Community Advisory Board Promoting Community Engagement in Cancer Research for Ethnically Diverse Population. American Journal of Men's Health 2024, 18(5). DOI: 10.1177/15579883241280826. PMID: 39340388; PMCID: PMC11440528.
  8. Sifat MS. Kenney S, Bekteshi V, Chiang SC, Ogunsanya ME, Boozary LK, Alexander AC,  Kendzor DE. The Association of Migration-Related Stress With Poor Mental Health Among Recently Resettled Afghan Refugees. Journal of Migration and Health. 2024, 10 (100282). DOI: 10.1016/j.jmh.2024.100282.
  9. Ogunsanya ME, Kaninjing E, Ellis T±, Morton DJ, McIntosh AG, Zhao J, Dickey SL, Kendzor DE, Dwyer K, Young ME, Odedina FT. Health-Related Quality of Life in Ethnically Diverse Black Prostate Cancer Survivors: A Convergent Parallel Mixed-Methods Approach. Quality of Life Research Journal. 2024, 33(10):2705-2719. DOI: https://doi.org/10.1007/s11136-024-03718-9.
  10. Ogunsanya ME, Kaninjing E, Ellis T±, Bamidele OO, Morton D, McIntosh A, Dickey S, Kendzor D, Dwyer J, Young ME, Odedina FT. Quality of Life Assessment Among Ethnically Diverse Black Prostate Cancer Survivors: A Constructivist Grounded Theory Approach. Journal of Cancer Survivorship. 2024: May. DOI: 10.1007/s11764-024-01619-x. PMID: 38805150.
  11. Ogunsanya ME, Wagner JL, Bennett K, Medina MS, Starnes S±, Planas LG. Debate as an Active Learning Pedagogy among Pharmacy Students in a Public Health Course. American Journal of Pharmaceutical Education. 2024 Jul;88(7):100724. DOI: https://doi.org/10.1016/j.ajpe.2024.100724.
  12. Abraham O, Agoke A, Sanuth K, Fapohunda A, Ogunsanya ME, Piper M, Trentham-Dietz A. Need for Culturally Competent and Responsive Cancer Education for African Immigrant Families and Youth Living in the United States. JMIR Cancer. 2024:Mar 6;10:e53956. doi: 10.2196/53956. PMID: 38447129; PMCID: PMC10955401
  13. Ogunsanya ME, Wagner JL, Bennett K, Medina MS, Starnes S±, Planas LG. Debate as an Active Learning Pedagogy among Pharmacy Students in a Public Health Course. Journal of Clinical and Translational Research. 2023:Dec 7;8(1):e10. doi: 10.1017/cts.2023.690. PMID: 38384902; PMCID: PMC10877524.
  14. Ogunsanya ME, Sifat M#, Bamidele OO, Ezenwankwo EF, Clifton S, Ton C±, Knight JM, Odedina FT, Greer JA, Dwyer K, Kendzor DE. Mobile Health (mHealth) Interventions in Prostate Cancer Survivorship - A Scoping Review. Journal of Cancer Survivorship. 2023:1;11. DOI: 10.1007/s11764-022-01328-3. Epub ahead of print. PMID: 36627464.
  15. Sifat MS, Ehlke SJ, Boozary LK¤, Alexander AC, Ogunsanya ME, Businelle MS, Kendzor DE. Greater Discrimination Frequency and Lower Distress Tolerance are Associated with Mental Problems among Racially Privileged and Minoritized Adults Accessing an Urban Day Shelter. Journal of Racial and Ethnic Health Disparities. 2023:1,6. DOI: 10.1007/s40615-022-01496-z. Epub ahead of print. PMID: 36607564.
  16. Iwuchukwu OF, Alozie UP, Fadesere J, Ogunsanya ME. Do Brighter Personalities Matter? Relationship between Personality and Job Satisfaction in Working Pharmacists. American Journal of Pharmacotherapy and Pharmaceutical Sciences. 2022:1;9. DOI:10.25259/AJPPS_15_2022.
  17. Walker MA∞, Lu G∞, Clifton S, Ogunsanya ME, Chong BF. Influence of Socio-demographic Factors in Patients with Cutaneous Lupus Erythematosus. Frontiers in Medicine (Lausanne). 2022:11;9. DOI: 10.3389/fmed.2022.916134. PMID: 35899206; PMCID: PMC9311297.
  18. Akin-Odanye EO, Ogunsanya ME, Lawal S, Sulaiman FA, Ogo CN. Resilience and Associated Factors in Men with Prostate Cancer. Journal of Positive Psychology and Counselling, June 2022:10.
  19. Ezenwankwo EF¤, Nnate DA¤, Oladoyinbo CA, Dogo HM, Idowu AA, Onyeso CP¤, Ogo CN, Ogunsanya ME, Bamidele O, Nnaji CA. Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis. Annals of Global Health. 2022;88(1): 29, 1–12. DOI: https://doi.org/10.5334/aogh.3519.  
  20. Bamidele OO, Alexis O, Ogunsanya ME, Greenley S, Worsley A, Mitchell E. Barriers and Facilitators to Accessing and Utilising Post-Treatment Psychosocial Support by Black Men Treated for Prostate Cancer - A Systematic Review and Qualitative Synthesis Prostate Cancer Survivors. Supportive Care in Cancer. 2022:30;5 3665-3690. DOI: https://doi.org/10.1007/s00520-021-06716-6.
  21. Ezenwankwo EF¤, Ogbodo VE¤, Alom GO¤, Nwadilibe IB, Ofodum CM, Nwankwo CA, Okigbo CC, Omeje CA, Onyebuchi SJ, Oladoyimbo CA, Ezeani A, Akin-Odanye EO, Ogunsanya ME. Behavioural Oncology Research in Africa: Lessons From The Last Two Decades and Key Considerations Moving Forward. Eur J Cancer Care (Engl). 2021:21:e13545. DOI: 10.1111/ecc.13545. Epub ahead of print. PMID: 34931724.
  22. Ogunsanya ME, Goetzinger E¤, Owopetu O, Chandler PD, O'Connor. Predictors of palliative care knowledge: Findings from the Health Information National Trends Survey. Cancer Epidemiology, Biomarkers & Prevention Journal, 2021 July;30(7):1433-1439; DOI: 10.1158/1055-9965.EPI-20-1790.

*Indicates graduate student¤, undergraduate student^, medical student∞, postdoc#, or pharmacy student± (underlined)